307 related articles for article (PubMed ID: 31838656)
1. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
Zhang S; Yang Z; Qi F
Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
[TBL] [Abstract][Full Text] [Related]
2. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
3. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
6. ALDH as a Stem Cell Marker in Solid Tumors.
Toledo-Guzmán ME; Hernández MI; Gómez-Gallegos ÁA; Ortiz-Sánchez E
Curr Stem Cell Res Ther; 2019; 14(5):375-388. PubMed ID: 30095061
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
Liao F; Zhang J; Hu Y; Najafabadi AH; Moon JJ; Wicha MS; Kaspo B; Whitfield J; Chang AE; Li Q
Cancer Immunol Immunother; 2022 Aug; 71(8):1959-1973. PubMed ID: 35098344
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs.
Hassani Najafabadi A; Zhang J; Aikins ME; Najaf Abadi ZI; Liao F; Qin Y; Okeke EB; Scheetz LM; Nam J; Xu Y; Adams D; Lester P; Hetrick T; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
Nano Lett; 2020 Oct; 20(10):7783-7792. PubMed ID: 32926633
[TBL] [Abstract][Full Text] [Related]
9. Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.
Chen W; Allen SG; Qian W; Peng Z; Han S; Li X; Sun Y; Fournier C; Bao L; Lam RHW; Merajver SD; Fu J
Small; 2019 Feb; 15(5):e1802891. PubMed ID: 30632269
[TBL] [Abstract][Full Text] [Related]
10. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma.
Prasmickaite L; Engesaeter BØ; Skrbo N; Hellenes T; Kristian A; Oliver NK; Suo Z; Maelandsmo GM
PLoS One; 2010 May; 5(5):e10731. PubMed ID: 20505780
[TBL] [Abstract][Full Text] [Related]
13. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
14. Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells.
Al-Shamma SA; Zaher DM; Hersi F; Abu Jayab NN; Omar HA
Life Sci; 2023 May; 320():121541. PubMed ID: 36870386
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
17. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Pietrobono S; Pandolfi S; Montagnani V; D'Amico M; Penachioni JY; Vinci MC; Borgognoni L; Stecca B
Oncogene; 2014 Sep; 33(38):4697-708. PubMed ID: 24681955
[TBL] [Abstract][Full Text] [Related]
18. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
[TBL] [Abstract][Full Text] [Related]
19. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.
Liu SY; Zheng PS
Oncotarget; 2013 Dec; 4(12):2462-75. PubMed ID: 24318570
[TBL] [Abstract][Full Text] [Related]
20. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis.
Sun S; Wang Z
Biochem Biophys Res Commun; 2010 Jun; 396(4):843-8. PubMed ID: 20450887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
